RXST:NASDAQ, RxSight, Inc.

RXST stock overview

RxSight, Inc. (RXST:NASDAQ) closed at $5.02 on October 23, 2026, down 1.18% on the day. The stock trades 62.0% below its 52-week high of $13.22 and 14.1% above its 52-week low of $4.40. Over the past year, it lost 41.7%. RxSight, Inc. is part of the Health Care sector.

Key figures

Price: $5.02
Day change: -1.18%
Volume: 326,803
Average volume: 810,104
Market cap: 208M+
52-week range: $4.40 – $13.22
50-day average: $5.58
200-day average: $6.51

Price action over the past year

In 252 trading sessions since October 23, 2025, RXST closed higher on 116 days (46%). Its best day was January 12, 2026 (+14.14%) and its worst was May 7, 2026 (-14.45%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Oct 24, 2026: News catalyst: Private Placement (News Catalysts scanner)
Oct 23, 2026: Down 31.1% over 180 days, from $7.29 (Dips & Crashes scanner)
Oct 23, 2026: Trading sideways between $4.51 and $5.08 over 30 days (Sideways scanner)

RXST news

Oct 24, 2026: RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Oct 20, 2026: RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
Oct 19, 2026: RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
Sep 23, 2026: RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says
Aug 26, 2026: RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
Aug 13, 2026: Could Alcon (ALC) and RxSight (RXST)'s Partnership Reshape the Future of Cataract Surgery?
Aug 12, 2026: RxSight (RXST) Q2 2026 Earnings Call Transcript
Aug 6, 2026: Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside

About RxSight, Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

Similar stocks

Find more stocks like RXST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.